US Stock MarketDetailed Quotes

LVTX LAVA Therapeutics

Watchlist
  • 1.110
  • -0.090-7.50%
Close Dec 13 16:00 ET
  • 1.140
  • +0.030+2.70%
Post 20:01 ET
29.19MMarket Cap-1.10P/E (TTM)

LAVA Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-21.43%-8.63M
35.83%-8.38M
86.50%-1.13M
-1,063.94%-38.97M
-129.29%-10.47M
50.45%-7.11M
-34.41%-13.07M
-9.27%-8.34M
114.11%4.04M
580.70%35.74M
Net income from continuing operations
-38.85%-12.2M
34.85%-8.21M
96.51%-484K
-31.70%-41.7M
56.65%-6.44M
-993.79%-8.79M
-56.95%-12.6M
-42.06%-13.87M
24.98%-31.66M
-81.92%-14.85M
Operating gains losses
251.86%1.72M
-38.93%-339K
-169.48%-658K
148.31%1.41M
-52.06%1.84M
54.99%-1.13M
92.22%-244K
185.16%947K
-43.28%-2.92M
389.81%3.84M
Depreciation and amortization
-33.33%212K
-22.71%228K
-21.09%247K
63.64%1.28M
29.89%352K
89.29%318K
69.54%295K
86.31%313K
39.96%781K
88.19%271K
Deferred tax
-88.24%-96K
12.37%-85K
2.82%-69K
-12.05%-279K
11.76%-60K
-10.87%-51K
-29.33%-97K
-18.33%-71K
-58.60%-249K
-17.24%-68K
Change In working capital
-18.40%1.3M
91.47%-133K
-118.24%-581K
-108.29%-2.83M
-113.16%-6.05M
111.69%1.6M
-266.38%-1.56M
268.75%3.19M
214.78%34.11M
6,216.35%45.98M
-Change in receivables
-87.75%399K
89.40%-254K
-41.10%758K
164.20%1.59M
-101.17%-557K
106.50%3.26M
-2,161.32%-2.4M
2,398.21%1.29M
-433.56%-2.48M
4,797.64%47.75M
-Change in prepaid assets
357.88%704K
-146.33%-947K
-60.36%463K
282.28%3.39M
164.83%446K
90.36%-273K
193.26%2.04M
20.91%1.17M
35.05%-1.86M
-140.52%-688K
-Change in payables and accrued expense
-141.80%-1.7M
-60.93%761K
0.11%-915K
-76.36%334K
-23.78%-4.76M
-18.06%4.07M
569.42%1.95M
-10,277.78%-916K
-12.67%1.41M
-698.44%-3.85M
-Change in other current liabilities
134.86%1.9M
109.73%307K
-153.86%-887K
-330.98%-8.14M
-144.27%-1.18M
-625.70%-5.45M
-588.99%-3.15M
70.32%1.65M
-75.48%3.52M
316.87%2.66M
-Change in other working capital
----
----
----
----
----
----
----
----
1,207.40%33.51M
107.79%106K
Cash from discontinued investing activities
Operating cash flow
-21.43%-8.63M
35.83%-8.38M
86.50%-1.13M
-1,063.94%-38.97M
-129.29%-10.47M
50.45%-7.11M
-34.41%-13.07M
-9.27%-8.34M
114.11%4.04M
580.70%35.74M
Investing cash flow
Cash flow from continuing investing activities
102.65%447K
51.34%339K
-90.65%718K
-288.69%-17.64M
-109.88%-8.69M
-355.95%-16.85M
-93.66%224K
127.74%7.68M
121.46%9.35M
-404.14%-4.14M
Net PPE purchase and sale
-250.00%-21K
101.34%3K
117.80%89K
-24.36%-730K
--0
-124.00%-6K
-833.33%-224K
-54.80%-500K
23.17%-587K
-57.74%-265K
Net investment purchase and sale
102.78%468K
-25.00%336K
-92.31%629K
-270.19%-16.91M
-124.24%-8.69M
-356.83%-16.84M
-87.40%448K
121.36%8.18M
123.22%9.93M
-493.26%-3.87M
Cash from discontinued investing activities
Investing cash flow
102.65%447K
51.34%339K
-90.65%718K
-288.69%-17.64M
-109.88%-8.69M
-355.95%-16.85M
-93.66%224K
127.74%7.68M
121.46%9.35M
-404.14%-4.14M
Financing cash flow
Cash flow from continuing financing activities
23.65%-368K
103.18%5K
0
-301.77%-571K
1,131.25%165K
-6,785.71%-482K
-536.11%-157K
-135.93%-97K
-99.81%283K
90.12%-16K
Net issuance payments of debt
23.24%-370K
92.36%-12K
91.75%-8K
-313.06%-571K
1,131.25%165K
-6,785.71%-482K
-847.62%-157K
-135.93%-97K
-21.18%268K
90.12%-16K
Net common stock issuance
----
----
----
--0
----
----
----
----
--0
----
Net preferred stock issuance
----
----
----
--0
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
--2K
--17K
--8K
--0
--0
--0
--0
--0
--15K
--0
Cash from discontinued financing activities
Financing cash flow
23.65%-368K
103.18%5K
--0
-301.77%-571K
1,131.25%165K
-6,785.71%-482K
-536.11%-157K
-135.93%-97K
-99.81%283K
90.06%-16K
Net cash flow
Beginning cash position
-59.95%35.09M
-57.07%43.19M
-55.92%44.23M
10.41%100.33M
-2.59%62.66M
15.47%87.61M
17.36%100.6M
10.41%100.33M
474.47%90.87M
-35.90%64.33M
Current changes in cash
65.01%-8.55M
38.14%-8.04M
46.09%-407K
-518.21%-57.18M
-160.12%-18.99M
-214.60%-24.44M
-111.25%-13M
81.06%-755K
-82.69%13.67M
475.24%31.58M
Effect of exchange rate changes
184.58%428K
-6,200.00%-61K
-162.09%-637K
125.57%1.08M
-87.45%555K
86.57%-506K
100.03%1K
188.52%1.03M
-7.43%-4.21M
508.97%4.42M
End cash Position
-56.97%26.96M
-59.95%35.09M
-57.07%43.19M
-55.92%44.23M
-55.92%44.23M
-2.59%62.66M
15.47%87.61M
17.36%100.6M
10.41%100.33M
10.41%100.33M
Free cash flow
-21.65%-8.65M
36.91%-8.38M
87.27%-1.13M
-1,248.78%-39.7M
-129.50%-10.47M
50.32%-7.11M
-36.38%-13.29M
-11.12%-8.84M
111.75%3.46M
566.59%35.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -21.43%-8.63M35.83%-8.38M86.50%-1.13M-1,063.94%-38.97M-129.29%-10.47M50.45%-7.11M-34.41%-13.07M-9.27%-8.34M114.11%4.04M580.70%35.74M
Net income from continuing operations -38.85%-12.2M34.85%-8.21M96.51%-484K-31.70%-41.7M56.65%-6.44M-993.79%-8.79M-56.95%-12.6M-42.06%-13.87M24.98%-31.66M-81.92%-14.85M
Operating gains losses 251.86%1.72M-38.93%-339K-169.48%-658K148.31%1.41M-52.06%1.84M54.99%-1.13M92.22%-244K185.16%947K-43.28%-2.92M389.81%3.84M
Depreciation and amortization -33.33%212K-22.71%228K-21.09%247K63.64%1.28M29.89%352K89.29%318K69.54%295K86.31%313K39.96%781K88.19%271K
Deferred tax -88.24%-96K12.37%-85K2.82%-69K-12.05%-279K11.76%-60K-10.87%-51K-29.33%-97K-18.33%-71K-58.60%-249K-17.24%-68K
Change In working capital -18.40%1.3M91.47%-133K-118.24%-581K-108.29%-2.83M-113.16%-6.05M111.69%1.6M-266.38%-1.56M268.75%3.19M214.78%34.11M6,216.35%45.98M
-Change in receivables -87.75%399K89.40%-254K-41.10%758K164.20%1.59M-101.17%-557K106.50%3.26M-2,161.32%-2.4M2,398.21%1.29M-433.56%-2.48M4,797.64%47.75M
-Change in prepaid assets 357.88%704K-146.33%-947K-60.36%463K282.28%3.39M164.83%446K90.36%-273K193.26%2.04M20.91%1.17M35.05%-1.86M-140.52%-688K
-Change in payables and accrued expense -141.80%-1.7M-60.93%761K0.11%-915K-76.36%334K-23.78%-4.76M-18.06%4.07M569.42%1.95M-10,277.78%-916K-12.67%1.41M-698.44%-3.85M
-Change in other current liabilities 134.86%1.9M109.73%307K-153.86%-887K-330.98%-8.14M-144.27%-1.18M-625.70%-5.45M-588.99%-3.15M70.32%1.65M-75.48%3.52M316.87%2.66M
-Change in other working capital --------------------------------1,207.40%33.51M107.79%106K
Cash from discontinued investing activities
Operating cash flow -21.43%-8.63M35.83%-8.38M86.50%-1.13M-1,063.94%-38.97M-129.29%-10.47M50.45%-7.11M-34.41%-13.07M-9.27%-8.34M114.11%4.04M580.70%35.74M
Investing cash flow
Cash flow from continuing investing activities 102.65%447K51.34%339K-90.65%718K-288.69%-17.64M-109.88%-8.69M-355.95%-16.85M-93.66%224K127.74%7.68M121.46%9.35M-404.14%-4.14M
Net PPE purchase and sale -250.00%-21K101.34%3K117.80%89K-24.36%-730K--0-124.00%-6K-833.33%-224K-54.80%-500K23.17%-587K-57.74%-265K
Net investment purchase and sale 102.78%468K-25.00%336K-92.31%629K-270.19%-16.91M-124.24%-8.69M-356.83%-16.84M-87.40%448K121.36%8.18M123.22%9.93M-493.26%-3.87M
Cash from discontinued investing activities
Investing cash flow 102.65%447K51.34%339K-90.65%718K-288.69%-17.64M-109.88%-8.69M-355.95%-16.85M-93.66%224K127.74%7.68M121.46%9.35M-404.14%-4.14M
Financing cash flow
Cash flow from continuing financing activities 23.65%-368K103.18%5K0-301.77%-571K1,131.25%165K-6,785.71%-482K-536.11%-157K-135.93%-97K-99.81%283K90.12%-16K
Net issuance payments of debt 23.24%-370K92.36%-12K91.75%-8K-313.06%-571K1,131.25%165K-6,785.71%-482K-847.62%-157K-135.93%-97K-21.18%268K90.12%-16K
Net common stock issuance --------------0------------------0----
Net preferred stock issuance --------------0------------------0----
Proceeds from stock option exercised by employees --2K--17K--8K--0--0--0--0--0--15K--0
Cash from discontinued financing activities
Financing cash flow 23.65%-368K103.18%5K--0-301.77%-571K1,131.25%165K-6,785.71%-482K-536.11%-157K-135.93%-97K-99.81%283K90.06%-16K
Net cash flow
Beginning cash position -59.95%35.09M-57.07%43.19M-55.92%44.23M10.41%100.33M-2.59%62.66M15.47%87.61M17.36%100.6M10.41%100.33M474.47%90.87M-35.90%64.33M
Current changes in cash 65.01%-8.55M38.14%-8.04M46.09%-407K-518.21%-57.18M-160.12%-18.99M-214.60%-24.44M-111.25%-13M81.06%-755K-82.69%13.67M475.24%31.58M
Effect of exchange rate changes 184.58%428K-6,200.00%-61K-162.09%-637K125.57%1.08M-87.45%555K86.57%-506K100.03%1K188.52%1.03M-7.43%-4.21M508.97%4.42M
End cash Position -56.97%26.96M-59.95%35.09M-57.07%43.19M-55.92%44.23M-55.92%44.23M-2.59%62.66M15.47%87.61M17.36%100.6M10.41%100.33M10.41%100.33M
Free cash flow -21.65%-8.65M36.91%-8.38M87.27%-1.13M-1,248.78%-39.7M-129.50%-10.47M50.32%-7.11M-36.38%-13.29M-11.12%-8.84M111.75%3.46M566.59%35.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data